Evidence map›Paper›PMID 40618999›Full record

ArticleMolecular & cellular proteomics : MCP2025

Extracellular Vesicles Bearing Vimentin Drive Epithelial-Mesenchymal Transition.

Sepideh Parvanian, Leila S Coelho-Rato, Michael Santos Silva, Giulia Sultana, Arun P Venu, Pallavi Vilas Devre, Mayank Kumar Modi, John E Eriksson

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Translational cancer research · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sepideh ParvanianCenter for Systems Biology, Massachusetts General Hospital Research Institute and Harvard Medical School, Boston, Massachusetts, USA; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland. Electronic address: sparvanian@mgh.harvard.edu.
Leila S Coelho-RatoTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Michael Santos SilvaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Giulia SultanaTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Arun P VenuTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Pallavi Vilas DevreTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
Mayank Kumar ModiTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland.
John E ErikssonTurku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland; Faculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku, Finland; Euro-Bioimaging ERIC, Turku, Finland. Electronic address: john.eriksson@abo.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-mesenchymal transition (EMT) is a key biological process in physiological and pathological conditions, spanning development, wound healing, and cancer. Vimentin, a key cytoskeletal intermediate filament (IF) protein, is an established intracellular determinant of EMT. Recently, extracellular vimentin has also emerged with important functions, and we demonstrated that vimentin from fibroblast-derived extracellular vesicles (EVs) promotes wound healing. Building on these findings, we explored whether extracellular vimentin regulates EMT. We employed fibroblast-derived EVs to assess their EMT-driving capacity. Using coculture models and EV treatments from WT and vimentin-KO fibroblasts, we observed that fibroblasts induce an EMT phenotype in epithelial cells, marked by elevated mesenchymal markers and reduced epithelial markers. EVs from vimentin-deficient fibroblasts showed a decreased EMT-inducing capacity and failed to stimulate cell cover closure, underscoring vimentin's critical role in orchestrating these processes. Coculturing epithelial cells with WT fibroblasts mirrored these outcomes, while vimentin-deficient fibroblasts produced similarly poor EMT induction. Proteomic profiling revealed that WT EVs contained an enriched set of EMT-associated proteins, including those involved in cytoskeletal organization, cell adhesion, and EMT-regulating signaling pathways. Notably, these proteins, such as fibronectin and N-cadherin, were significantly diminished in vimentin-deficient EVs. Moreover, we identified over 600 additional proteins uniquely present in WT-derived EVs, with enrichment in key biological processes like wound healing and cell migration. These findings demonstrate that vimentin-positive EVs drive EMT by transmitting a specific protein cargo that supports EMT-related cellular changes. The vimentin-positive EV proteome will help understand EMT mechanisms and develop targeted therapies for pathological conditions related to abnormal EMT.

Indexed as

Epithelial-Mesenchymal TransitionExtracellular VesiclesFibroblastsVimentinBiomarkers, TumorCoculture TechniquesEpithelial CellsHumansMass SpectrometryMCF-7 CellsMDA-MB-231 CellsNeoplasm InvasivenessNeoplasmsProteomicsWound HealingBiomarkers, TumorVimentinepithelial–mesenchymal transitionextracellular vesiclesextracellular vimentinfibroblast

Identifiers

PMID40618999
PMCPMC12719745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.